Or6c5b, a member of the olfactory receptor family 6 subfamily C, plays a crucial role in the olfactory system by interacting with odorant molecules, initiating neuronal responses, and ultimately leading to the perception of specific smells. As a G-protein-coupled receptor (GPCR), Or6c5b shares a structural domain with neurotransmitter and hormone receptors, contributing to the extensive diversity within the olfactory receptor gene family, the largest in the genome. Activation of Or6c5b involves a complex interplay of signaling pathways and cellular processes. The identified chemicals, acting as direct or indirect activators, target specific mechanisms to influence Or6c5b expression. Retinoic Acid, for instance, directly up-regulates Or6c5b by binding to retinoic acid response elements, enhancing olfactory signal transduction. Forskolin and 8-Br-cAMP stimulate the cAMP-PKA pathway, positively modulating Or6c5b expression and intensifying odorant perception.
Inhibition of PKA by H89 negatively impacts Or6c5b, highlighting the regulatory role of PKA in olfactory receptor function. Indirect modulators like BAPTA-AM, Wortmannin, and U0126 disrupt intracellular calcium dynamics or key kinase activities, influencing Or6c5b expression through related pathways. The interconnected nature of PI3K-Akt signaling, targeted by LY294002, also indirectly regulates Or6c5b, emphasizing the complexity of olfactory receptor activation. Hemin, through the heme-HO-CO pathway, represents a novel mechanism for indirect modulation, while GW5074 targets the Ras-Raf-MEK-ERK pathway to impact Or6c5b expression. A23187 and SQ22536 influence intracellular calcium levels and adenylate cyclase activity, respectively, contributing to the indirect modulation of Or6c5b. In summary, Or6c5b activation involves a sophisticated network of signaling pathways influenced by specific chemicals. Understanding these interactions provides valuable insights into the intricate regulation of olfactory receptor function, contributing to our comprehension of odorant perception at the molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid acts as a ligand for nuclear receptors, influencing the RAR/RXR pathway. It directly up-regulates Or6c5b expression by binding to retinoic acid response elements in its promoter region, enhancing olfactory signal transduction via GPCR-mediated pathways. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Br-cAMP, a cAMP analog, directly activates PKA, positively modulating Or6c5b expression. This chemical enhances olfactory signal transduction by promoting the cAMP-PKA pathway, resulting in the up-regulation of the target protein and intensified odorant perception. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM chelates intracellular calcium, affecting Ca2+-dependent signaling. Disruption of Ca2+ homeostasis indirectly modulates Or6c5b by influencing downstream pathways. Altered intracellular calcium dynamics contribute to the regulation of olfactory receptor activation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin inhibits PI3-kinase, impacting the PI3K-Akt pathway. This inhibition indirectly affects Or6c5b, suggesting a potential role for the PI3K-Akt cascade in modulating olfactory receptor function. Wortmannin-induced changes contribute to enhanced olfactory perception. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK, a kinase in the MAPK pathway. This inhibition modulates downstream targets, potentially including Or6c5b. The MAPK pathway's involvement in olfactory signal transduction implies an indirect regulatory role for U0126 in modulating the target protein's expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3-kinase, influencing the PI3K-Akt pathway. Indirect modulation of Or6c5b occurs through disrupted PI3K-Akt signaling, highlighting the interconnected nature of these pathways in regulating olfactory receptor activation and odorant perception. | ||||||
Hemin chloride | 16009-13-5 | sc-202646 sc-202646A sc-202646B | 5 g 10 g 25 g | $102.00 $160.00 $326.00 | 9 | |
Hemin activates heme oxygenase, producing carbon monoxide (CO). CO serves as a signaling molecule, potentially influencing Or6c5b expression. The heme-HO-CO pathway represents a novel mechanism for indirect modulation of olfactory receptor activity, contributing to enhanced odor perception. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
GW5074 inhibits Raf-1 kinase, affecting the Ras-Raf-MEK-ERK pathway. This inhibition indirectly impacts Or6c5b, suggesting a role for the Ras-Raf-MEK-ERK cascade in modulating olfactory signal transduction. GW5074-induced changes contribute to the up-regulation of the target protein. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 induces intracellular calcium release, affecting Ca2+-dependent signaling. Altered calcium dynamics indirectly modulate Or6c5b expression, suggesting a role for Ca2+ signaling in regulating olfactory receptor activation and enhancing the perception of specific odorants. | ||||||
SQ 22536 | 17318-31-9 | sc-201572 sc-201572A | 5 mg 25 mg | $95.00 $363.00 | 13 | |
SQ22536 inhibits adenylate cyclase, decreasing cAMP levels. Reduced cAMP signaling negatively impacts Or6c5b, indicating a regulatory role for adenylate cyclase in olfactory receptor function. SQ22536-induced suppression represents an indirect modulator of Or6c5b. | ||||||